Familial hypertrophic cardiomyopathy (FHC) is an inherited autosomal dominant disease
caused by mutations in sarcomeric proteins. Among these, mutations that affect myosin binding …

Chronic pain interrupts behaviour, interferes with functioning, and may affect a person's
identity: their sense of self. We tested whether loss of role and personal attributes and current …

In the 20 years since the discovery of the first mutation linked to familial hypertrophic
cardiomyopathy (HCM), an astonishing number of mutations affecting numerous sarcomeric …

Cardiac myosin-binding protein C (cMyBP-C) is a regulatory protein expressed in cardiac
sarcomeres that is known to interact with myosin, titin, and actin. cMyBP-C modulates …

Background Sphingosine-1-phosphate receptor (S1P) modulators and anti-CD20 therapies
impair humoral responses to SARS-CoV-2 mRNA vaccines. Relatively few studies have …

Myosin binding protein-C (MyBP-C) is localized to the thick filaments of striated muscle where
it appears to have both structural and regulatory functions. Importantly, mutations in the …

Introduction The mandibular first molar is the most frequently endodontically treated tooth
and is extremely anatomically challenging. The purpose of this micro–computed tomographic …

The COVID-19 pandemic caused immediate and far-reaching disruption to society, the
economy, and health-care services. We synthesised evidence on the effect of the pandemic on …

Hypertrophic cardiomyopathy (HCM) is an inherited disease of the heart muscle characterized
by otherwise unexplained thickening of the left ventricle. Left ventricular outflow tract (…

Myosin binding protein-C (MyBP-C) is a thick-filament protein whose precise function within
the sarcomere is not known. However, recent evidence from cMyBP-C knock-out mice that …